
Alzamend Neuro Inc
ALZNHealthcare|Biotechnology|US
$1.41
-0.14 (-9.03%)
Tangible Book / Share
$1.30
Cash / Share
$1.70
Next Earnings Report
Dec 8, 2026
EPS est. -$0.23
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Aug 21, 2026 (S-1). Possible dilution.
Upcoming Data Readouts (2)
Dec 2026
Est. completion
P1P2Bipolar I Disorder
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder
NCT07540338n=20
Mar 2028
Est. completion
Recent Press Releases
SEC Filings (46)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 9, 2026 | RW | DocumentIndex | |
| Sep 29, 2026 | 8-K | Material event | DocumentIndex |
| Sep 10, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 28, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Aug 21, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Aug 3, 2026 | 8-K | Material event | DocumentIndex |
| Jul 22, 2026 | 10-K | Annual report | DocumentIndex |
| Jul 21, 2026 | 8-K | Material event | DocumentIndex |
| Apr 17, 2026 | 8-K | Material event | DocumentIndex |
| Mar 20, 2026 | 8-K | Material event | DocumentIndex |
| Mar 11, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Mar 6, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Mar 6, 2026 | 8-K | Material event | DocumentIndex |
| Feb 26, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Feb 26, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Feb 9, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Dec 9, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 18, 2025 | 8-K | Material event | DocumentIndex |
| Oct 14, 2025 | 8-K | Material event | DocumentIndex |
| Oct 9, 2025 | 8-K | Material event | DocumentIndex |
| Oct 7, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Oct 3, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Sep 30, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Sep 25, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Sep 25, 2025 | 8-K | Material event | DocumentIndex |
| Sep 23, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Sep 10, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 1, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Aug 1, 2025 | 8-K | Material event | DocumentIndex |
| Jul 23, 2025 | 8-K | Material event | DocumentIndex |
| Jul 9, 2025 | 8-K | Material event | DocumentIndex |
| May 8, 2025 | 8-K | Material event | DocumentIndex |
| Apr 25, 2025 | 8-K | Material event | DocumentIndex |
| Apr 9, 2025 | 424B3 | Offering prospectus | DocumentIndex |
| Apr 8, 2025 | EFFECT | DocumentIndex | |
| Mar 27, 2025 | S-1/A | IPO / offering registration | DocumentIndex |
| Mar 19, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Mar 17, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Mar 13, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 13, 2025 | S-3 | Shelf registration | DocumentIndex |